New in neuroprotective therapy for children with aseptic meningitis.
https://doi.org/10.22625/2072-6732-2014-6-2-59-64
Abstract
Aim: assessment of efficienty of Nooclerin in children with aseptic meningitis.
Materials and methods: our study was performed on 50 children with aseptic meningitis; efficiency of Nooclerin was analized. First group (main, 35 patients) took standart therapy and Nooclerin from the 5th day of hospitalization within 2 months; s cond group (control, 15 patients) took only standart treatment. During the whole period of hospitalization and 2 months after all patients were monitored with clinilalneurological signs. Assessment of asthenia was performed on the «Children asthenia’s symptoms scale» and «Schatz asthenia scale». Also we defined the quality of life by means of questionnaire PedsQL4.0; EEG was conducted twice: first days of hospitalization and 2 months after discharge from the hospital.
Results: we analized including of Nooclerin in the therapy of aseptic meningitis leads to significant decrease of asthenic syndrome and increase the quality of life compare to control group.
Conclusion. We recommend to include Nooclerin in standarts of management of children with aseptic meningitis.
About the Authors
M. V. Ivanova
Science Research Institute of Children’s Infections of FMBA of Russia, Saint-Peterburg, Russia
Russian Federation
Russian Federation
N. V. Skripchenko
Science Research Institute of Children’s Infections of FMBA of Russia, Saint-Peterburg, Russia
Russian Federation
Russian Federation
N. V. Matyunina
Science Research Institute of Children’s Infections of FMBA of Russia, Saint-Peterburg, Russia
Russian Federation
Russian Federation
A. A. Vilnits
Science Research Institute of Children’s Infections of FMBA of Russia, Saint-Peterburg, Russia
Russian Federation
Russian Federation
V. B. Voytenkov
Science Research Institute of Children’s Infections of FMBA of Russia, Saint-Peterburg, Russia
Russian Federation
Russian Federation
References
1. Lobzin Yu.V., Skripchenko, N.V., Murina E.A. Enteroviral infection, S-Pb., 2012/ – 432 p.
2. Mixailova E.V., Shteinberg A.V., Eremeeva I.G. Infechionnie bolezni – 2008. – 6 (1). – P. 31–34.
3. Skripchenko, N.V., Sorokina M.N. Viral encephalitis and meningitis inchildren. Moscow: Medicine, 2004. –415p.
4. Shteinberg A.V., Ivanova G.P. et al Methodological guidelines – S-Pb.: – 2013. – 18 p.
5. Avedisova A.S. Pharmoteka. – 2005. – №6. – P. 51-54
6. Aleksandrovski Yu.A., Avedisova A.S., Yastrebov D.V. Psixiatriya i psixofarmakoterapiya. – 2003. – №6. –P . 51–54
7. Lukianova E.M. Kachestvennaia klinicheskaia praktika. – 2002. – №4. – P. 34-42.
Review
For citations:
Ivanova M.V., Skripchenko N.V., Matyunina N.V., Vilnits A.A., Voytenkov V.B. New in neuroprotective therapy for children with aseptic meningitis. Journal Infectology. 2014;6(2):59-64. (In Russ.) https://doi.org/10.22625/2072-6732-2014-6-2-59-64
Views:
690
.png)
.png)
Email this article 